TABLE OF CONTENTS
DECLARA TTON .................................................................... i
DEDIC AT! ON .............................................................................. !
ACKNOWLEDGEMENT .................................................. 2
ABSTRACT ............................................................... 6
CHAPTER I : .................................................................... 7
1.0 Introduction .................................... 7 1.1
Backgro............................................ 7
1.1 Background .................................................................. 7
1.2 Problem statement ........................................................... 8
1.3.0 General objectives ....................................................... 9
1.3.1 Specific objectives ......................................................... 9
1.4.0 Study hypothesis ....................................................... 9
1.4.1 Null hypothesis ........................................... 9
1.4.2 Alternative hypothesis ................................................ 9
1.5.0 Scope of the Study ................................................................ 9
1.5.1 Time Scope ..................................................................... 9
1.5.2 Content Scope ........................................................... 9
1.5.3 Geographical Scope .................................................... 9
1.6 Justification the study ................................................... 10
CHAPTER 2: ............................................................................ 11
2.0 LITERATURE REVIEW ..................................................... 11
2.1 Malaria prevalence ....................................................... 11
2.2 Malaria and gametocyte carriage .......................................... 12
2.3 Malaria treatment. ..................................................... 13
CHAPTER 3: ........................................................................ 15
3.0 METHODOLOGY: ................................................................... 15
3.1 Study Design ............................................................ 15
3.2 Study Setting ............................................................ 15
3.4 Stndy Population ...................................................... 15
3.5 Sample Size ................................................................... 15
3.6 Inclusion Criteria ..................................................................... 16
3.7 Exclusion Criteria ....................................................................... 16
BPH/0014/113/DU
Page 3
3.8 Sampling Techniques .......................................................... 16
3.9 Data Collection Procedures: .............................................. 16
3.9.1 Questionnaire ............................................................ 16
3.9.2 Laboratory Investigation .............................................. 17
3.10 Outcome Measures ............................................................. 19
3.11 Data Analysis Procedures .................................................. 19
3.12 Ethical Considerations .............................................. 19
4.0 Study findings ......................................................... 20
4.1 Introductions ................................................................. 20
4.1 Study Findings ......................................................................... 20
Discussions ................................................................................. 31
5.0 Introductions ........................................................... 31
5.1 Demographic charateristicts ................. : ................... 31
5.2 Prevalence rate of malaria among children at Ishaka Adventist Hospital.. ............................. 31
5.3 treatment given to children with malaria at Ish aka Adventist Hospital .................................. 32
5.4 To determine the gametocyte carriage in children with malaria at Ishaka Adventist Hospital........................... 32
5.3 conclusion .......................................................................... 32
5.4 recommendation ......................................................... 'ljl
CHAPTER SIX ..................................................................... 34
REFERENCES ............................................................... 34
CHAPTER SEVEN ................................................................. 36
APPENDIX I ....................................................................... 36
APPENDIX 2: .................................................................. 39
APPENDIX 3 ...................................... Error! Bookmark not defined.
BPH/0014/113/DU
Page 4
ABSTRACT
Background Malaria is endemic in I 07 countries and territories in tropical and subtropical regions, with
sub-Saharan African hit hardest and is highly endemic in 95% of Uganda with
approximately 90% of the population (estimated at 32 million people) at risk. The remaining
5% of the country consists of unstable and epidemic-prone transmission areas in the
highlands of the south and west, along the eastern border with Kenya, and the northeastern
border with South Sudan. Malaria transmission is persistently high in some areas of northem
Uganda.
Methodology
A prospective cross sectional study was carried out involving_ both qualitative and quantitative
methods of data collection
Results
The study found out that the prevalence rate of malaria among children treated at Ishaka
Adventist Hospital was 23%, all children were given paracetamol most children were given
coartem (Artmether Lumefantrine), some few were given iv attesunate and quinine Health
Centre and the gametocytes carriage in children with malaria at lshaka Adventist Hospital
was 21%.
Conclusion
The prevalence rate of malaria among children treated at lshaka Adventist Hospital was low
coartem (Artmether Lumefantrine), iv artesunate and quinine were the drugs used to treat
malaria
The gametocytes carriage in children with malaria at Ishaka Adventist Hospital was low.
The altemative hypothesis that determination of the prevalence, treatment, and gametocyte
carnage is important in reducing the morbidity and mortality of children with malaria
remains
BPH/0014/113/DU
Page 6
Research, S. (2022). Prevalence, Treatment, And Gametocyte Carriage In Cidldren With Malaria At Ishaka Adventist Hospital. Afribary. Retrieved from https://track.afribary.com/works/prevalence-treatment-and-gametocyte-carriage-in-cidldren-with-malaria-at-ishaka-adventist-hospital
Research, SSA "Prevalence, Treatment, And Gametocyte Carriage In Cidldren With Malaria At Ishaka Adventist Hospital" Afribary. Afribary, 22 Aug. 2022, https://track.afribary.com/works/prevalence-treatment-and-gametocyte-carriage-in-cidldren-with-malaria-at-ishaka-adventist-hospital. Accessed 19 Nov. 2024.
Research, SSA . "Prevalence, Treatment, And Gametocyte Carriage In Cidldren With Malaria At Ishaka Adventist Hospital". Afribary, Afribary, 22 Aug. 2022. Web. 19 Nov. 2024. < https://track.afribary.com/works/prevalence-treatment-and-gametocyte-carriage-in-cidldren-with-malaria-at-ishaka-adventist-hospital >.
Research, SSA . "Prevalence, Treatment, And Gametocyte Carriage In Cidldren With Malaria At Ishaka Adventist Hospital" Afribary (2022). Accessed November 19, 2024. https://track.afribary.com/works/prevalence-treatment-and-gametocyte-carriage-in-cidldren-with-malaria-at-ishaka-adventist-hospital